Table 2.
Indication of MSE exploration in patients with suspected SB strictures.
| Clinical presentation | Pre-enteroscopy diagnostic procedure | Stricture location |
Route of enteroscopy exploration | MSE Technical success |
MSE Diagnostic yield |
Stricture confirmed | Intervention | Total AE |
|---|---|---|---|---|---|---|---|---|
| Suspected IBD, chronic diarrhea with inflammatory biomarkers (n = 13) |
CE (3) CT scan (2) MRI-enterography (8) |
Proximal jejunum (3) Distal jejunum (2) Proximal ileum (2) Distal ileum (6) |
Oral (7) Anal (6) |
100% (13/13) | 69.2% (9/13) | 46.2% (6/13) |
Endoscopic balloon dilation (3) APC (1) Biopsy (9) |
Abdominal pain (1) |
| Chronic anemia (n = 9) |
CE (8) CT scan (1) |
Proximal jejunum (1) Distal jejunum (2) Proximal ileum (2) Distal ileum (4) |
Oral (5) Anal (4) |
88.8% (8/9) | 77.7% (7/9) | 66.6% (6/9) |
Endoscopic balloon dilation (2) Biopsy (7) |
– |
| Abdominal pain (n = 23) |
CT scan (10) MRI-enterography (12) CE (1) |
Proximal jejunum (1) Distal jejunum (3) Proximal ileum (4) Distal ileum (15) |
Oral (8) Anal (15) |
82.6% (19/23) | 52.2% (12/23) | 47.8% (11/23) |
Capsule Endoscopy extraction (1) Endoscopic balloon dilation (2) Biopsy (16) |
Abdominal pain (2) Difficult withdrawal through the esophagus (1) |
| Incidental finding (n = 4) | CT scan (4) |
Proximal jejunum (1) Distal jejunum (1) Proximal ileum (0) Distal ileum (2) |
Oral (3) Anal (1) |
50% (2/4) | 25% (n = 1) | – | – | – |
AE adverse events, CE capsule endoscopy; CT coaxial tomography, IBD inflammatory bowel disease; MRI magnetic resonance imaging.